P. Horby

Most-cited papers

1. A novel coronavirus outbreak of global health concern

   Chen Wang, P. Horby, F. Hayden, G. Gao

   2020The Lancet6,802 citations Open access

   Semantic Scholar

   Save

2. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

   Ye-Ming Wang, Ding-Yu Zhang, G. Du, Rong-Hui Du +42 more

   2020The Lancet3,160 citations Open access

   Semantic Scholar

   Save

3. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

   Obbina Ali Fatima Mustafa Sadia Hakam Alfie Nabeel Ashraf Abani Abbas Abbas Abbas Abbasi Abbass Abbott Abdal, O. Abani, A. Abbas, F. Abbas +496 more

   2021The Lancet1,685 citations Open access

   Semantic Scholar

   Save

4. Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19

   P. Horby, M. Mafham, L. Linsell, Jennifer L. Bell +25 more

   2020New England Journal of Medicine986 citations Open access

   Semantic Scholar

   Save

5. Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis.

   M. Shankar-Hari, C. Vale, P. Godolphin, D. Fisher +63 more

   2021Journal of the American Medical Association (JAMA)592 citations Open access

   Semantic Scholar

   Save

6. Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study

   A. Clift, C. Coupland, R. Keogh, K. Diaz-Ordaz +19 more

   2020British medical journal521 citations Open access

   Semantic Scholar

   Save

7. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

   P. Horby, M. Mafham, L. Peto, M. Campbell +30 more

   2021medRxiv446 citations Open access

   Semantic Scholar

   Save

8. Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

   P. Horby, L. Estcourt, L. Peto, J. Emberson +33 more

   2021medRxiv427 citations Open access

   Semantic Scholar

   Save

9. Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

   Eugenia Mustafa Sadia Alfie Ashraf Sherif Mohamed Basir Al Abaleke Abbas Abbasi Abbott Abdelaziz Abdelbadiee , E. Abaleke, M. Abbas, Sadia Abbasi +496 more

   2021The Lancet289 citations Open access

   Semantic Scholar

   Save

10. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial

    P. Horby, M. Campbell, N. Staplin, E. Spata +29 more

    2021medRxiv285 citations Open access

    Semantic Scholar

    Save

11. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

    P. Horby, J. Emberson, M. Mafham, M. Campbell +29 more

    2022medRxiv269 citations Open access

    Semantic Scholar

    Save

12. Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    P. Horby, G. Pessoa-Amorim, N. Staplin, J. Emberson +31 more

    2021medRxiv264 citations Open access

    Semantic Scholar

    Save

13. How the COVID-19 pandemic will change the future of critical care

    Y. Arabi, É. Azoulay, H. Al-Dorzi, J. Phua +20 more

    2021Intensive Care Medicine205 citations Open access

    Semantic Scholar

    Save

14. Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    P. Horby, M. Campbell, E. Spata, J. Emberson +31 more

    2021medRxiv172 citations Open access

    Semantic Scholar

    Save

15. Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID‐19

    D. Munblit, P. Bobkova, E. Spiridonova, A. Shikhaleva +64 more

    2021Clinical and Experimental Allergy165 citations Open access

    Semantic Scholar

    Save

16. Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: rapid review

    A. Dagens, L. Sigfrid, E. Cai, S. Lipworth +5 more

    2020British medical journal161 citations Open access

    Semantic Scholar

    Save

17. A second update on mapping the human genetic architecture of COVID-19

    Masahiro Shea J. Mattia Christine Benjamin M. Mark Andrea G Kanai Andrews Cordioli Stevens Neale Daly Ganna Pa, Masahiro Shea J. Mattia Christine Benjamin M. Mark Andrea Kanai Andrews Cordioli Stevens Neale Daly Ganna, Masahiro Kanai, S. Andrews +496 more

    2022Nature108 citations Open access

    Semantic Scholar

    Save

18. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

    O. A. F. J. K. M. S. H. A. Abani Abbas Abbas Abbas Abbas Abbas Abbasi Abbass, O. Abani, A. Abbas, F. Abbas +496 more

    2023The Lancet103 citations Open access

    Semantic Scholar

    Save

19. Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study

    Martina Patone, K. Thomas, R. Hatch, P. Tan +8 more

    2021Lancet. Infectious Diseases (Print)82 citations Open access

    Semantic Scholar

    Save

20. Human infection with a reassortment avian influenza A H3N8 virus: an epidemiological investigation study

    P. Bao, Yang Liu, Xiao-Ai Zhang, Hang Fan +18 more

    2022Nature Communications80 citations Open access

    Semantic Scholar

    Save

21. Creating a Framework for Conducting Randomized Clinical Trials during Disease Outbreaks

    N. Dean, Pierre-Stéphane Gsell, R. Brookmeyer, Forrest W. Crawford +15 more

    2020New England Journal of Medicine69 citations Open access

    Semantic Scholar

    Save

22. Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing

    A. Salam, A. Duvignaud, M. Jaspard, D. Malvy +4 more

    2022PLoS Neglected Tropical Diseases67 citations Open access

    Semantic Scholar

    Save

23. Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020

    C. Thompson, N. Grayson, Robert S Paton, J. Bolton +361 more

    2020Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin67 citations Open access

    Semantic Scholar

    Save

24. Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective cohort study

    A. Duvignaud, M. Jaspard, I. Etafo, D. Gabillard +44 more

    2021Lancet Global Health62 citations Open access

    Semantic Scholar

    Save

25. Potential health and economic impacts of dexamethasone treatment for patients with COVID-19

    R. Águas, Adam Mahdi, R. Shretta, P. Horby +83 more

    2021Nature Communications60 citations Open access

    Semantic Scholar

    Save

26. Addressing challenges for clinical research responses to emerging epidemics and pandemics: a scoping review

    L. Sigfrid, Katherine Maskell, P. Bannister, Sharif A. Ismail +9 more

    2020BMC Medicine60 citations Open access

    Semantic Scholar

    Save

27. Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19

    C. Kartsonaki, J. Baillie, N. G. Barrio, J. Baruch +55 more

    2023International Journal of Epidemiology58 citations Open access

    Semantic Scholar

    Save

28. Making trials part of good clinical care: lessons from the RECOVERY trial

    G. Pessoa-Amorim, M. Campbell, L. Fletcher, P. Horby +3 more

    2021Future healthcare journal57 citations Open access

    Semantic Scholar

    Save

29. Core Outcome Measures for Trials in People With Coronavirus Disease 2019: Respiratory Failure, Multiorgan Failure, Shortness of Breath, and Recovery

    A. Tong, A. Baumgart, N. Evangelidis, A. Viecelli +42 more

    2021Critical Care Medicine56 citations Open access

    Semantic Scholar

    Save

30. Time to reconsider the role of ribavirin in Lassa fever

    A. Salam, V. Cheng, T. Edwards, P. Olliaro +2 more

    2021PLoS Neglected Tropical Diseases55 citations Open access

    Semantic Scholar

    Save

31. Core Outcomes Set for Trials in People With Coronavirus Disease 2019

    A. Tong, Julian H. Elliott, L. Azevedo, A. Baumgart +41 more

    2020Critical Care Medicine52 citations Open access

    Semantic Scholar

    Save

32. Lassa fever in pregnancy: a systematic review and meta-analysis

    N. Kayem, C. Benson, Christina Y. L. Aye, S. Barker +4 more

    2020Transactions of the Royal Society of Tropical Medicine and Hygiene52 citations Open access

    Semantic Scholar

    Save

33. Case numbers of acute hepatitis of unknown aetiology among children in 24 countries up to 18 April 2022 compared to the previous 5 years

    Janko van Beek, Pieter la Fraaij, C. Giaquinto, D. Shingadia +58 more

    2022Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin51 citations Open access

    Semantic Scholar

    Save

34. The burden and dynamics of hospital-acquired SARS-CoV-2 in England

    B. Cooper, Stephanie Evans, Y. Jafari, Thi Mui Pham +14 more

    2023Nature50 citations Open access

    Semantic Scholar

    Save

35. Availability, scope and quality of monkeypox clinical management guidelines globally: a systematic review

    E. Webb, I. Rigby, M. Michelen, A. Dagens +18 more

    2022BMJ Global Health50 citations Open access

    Semantic Scholar

    Save

36. An evaluation of global Chikungunya clinical management guidelines: A systematic review

    E. Webb, M. Michelen, I. Rigby, A. Dagens +18 more

    2022EClinicalMedicine47 citations Open access

    Semantic Scholar

    Save

37. Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis

    Jiu-Yang Xu, Chaolin Huang, G. Fan, Zhi-Bo Liu +16 more

    2020Frontiers in Medicine43 citations Open access

    Semantic Scholar

    Save

38. A novel coronavirus outbreak of global health concern (vol 395, pg 470, 2020)

    Chen Wang, P. Horby, F. Hayden, G. F. Gao

    202042 citations

    Semantic Scholar

    Save

39. The European clinical research response to optimise treatment of patients with COVID-19: lessons learned, future perspective, and recommendations

    H. Goossens, L. Derde, P. Horby, M. Bonten

    2021Lancet. Infectious Diseases (Print)40 citations Open access

    Semantic Scholar

    Save

40. Edinburgh Research Explorer Features of 20133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study

    A. Docherty, E. Harrison, Christopher A. Green, H. Hardwick +21 more

    202040 citations

    Semantic Scholar

    Save

41. Seroprevalence and Virologic Surveillance of Enterovirus 71 and Coxsackievirus A6, United Kingdom, 2006–2017

    E. Kamau, Dung Nguyen, C. Celma, S. Blomqvist +3 more

    2021Emerging Infectious Diseases39 citations Open access

    Semantic Scholar

    Save

42. Lack of Evidence for Ribavirin Treatment of Lassa Fever in Systematic Review of Published and Unpublished Studies

    Hung-Yuan Cheng, C. French, A. Salam, S. Dawson +5 more

    2022Emerging Infectious Diseases36 citations Open access

    Semantic Scholar

    Save

43. Corticosteroid therapy for critically ill patients with COVID-19: A structured summary of a study protocol for a prospective meta-analysis of randomized trials

    J. Sterne, J. Diaz, J. Villar, S. Murthy +21 more

    2020Trials36 citations Open access

    Semantic Scholar

    Save

44. The value of open-source clinical science in pandemic response: lessons from ISARIC

    Ali Sheryl Ann Nurul Najmee Ryuzo Laurent Lara Subhash Abbas Abdukahil Abdulkadir Abe Abel Absil Acharya , A. Abbas, S. Abdukahil, Nurul Najmee Abdulkadir +496 more

    2021Lancet. Infectious Diseases (Print)34 citations Open access

    Semantic Scholar

    Save

45. Analysis of severe outcomes associated with the SARS-CoV-2 Variant of Concern 202012/01 in England using ICNARC Case Mix Programme and QResearch databases.

    Martina Patone, K. Thomas, Robert D. Hatch, P. Tan +8 more

    2021medRxiv34 citations Open access

    Semantic Scholar

    Save

46. Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol

    S. Knight, Rishi K. Gupta, A. Ho, R. Pius +31 more

    2021Thorax33 citations Open access

    Semantic Scholar

    Save

47. Preprints in times of COVID19: the time is ripe for agreeing on terminology and good practices

    R. Ravinetto, C. Caillet, M. Zaman, J. Singh +10 more

    2021BMC Medical Ethics28 citations Open access

    Semantic Scholar

    Save

48. Toward Consensus on Correct Interpretation of Protein Binding in Plasma and Other Biological Matrices for COVID‐19 Therapeutic Development

    M. Boffito, D. Back, C. Flexner, P. Sjö +6 more

    2020Clinical pharmacology and therapy28 citations Open access

    Semantic Scholar

    Save

49. A randomised trial of treatments to prevent death in patients hospitalised with COVID-19 (coronavirus)

    P. Horby, M. Nunn

    2020http://isrctn.com/28 citations

    Semantic Scholar

    Save

50. Azithromycin in Hospitalised Patients with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    P. Horby, A. Roddick, E. Spata, N. Staplin +30 more

    2020medRxiv22 citations Open access

    Semantic Scholar

    Save